Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 142

1.

Ontogeny of biphasic locomotor effects of quinpirole.

Van Hartesveldt C, Meyer ME, Potter TJ.

Pharmacol Biochem Behav. 1994 Jul;48(3):781-6.

PMID:
7938135
2.

Sulpiride antagonizes the biphasic locomotor effects of quinpirole in weanling rats.

Frantz KJ, Van Hartesveldt C.

Psychopharmacology (Berl). 1995 Jun;119(3):299-304.

PMID:
7675965
3.

Temporal and environmental effects on quinpirole-induced biphasic locomotion in rats.

Van Hartesveldt C.

Pharmacol Biochem Behav. 1997 Dec;58(4):955-60.

PMID:
9408200
4.
5.

Developmental treatment with the dopamine D2/3 agonist quinpirole selectively impairs spatial learning in the Morris water maze.

Vorhees CV, Johnson HL, Burns LN, Williams MT.

Neurotoxicol Teratol. 2009 Jan-Feb;31(1):1-10. doi: 10.1016/j.ntt.2008.09.003. Epub 2008 Sep 30.

PMID:
18930132
6.

Ontogenetic quinpirole treatments fail to prime for D2 agonist-enhancement of locomotor activity in 6-hydroxydopamine-lesioned rats.

Brus R, Kostrzewa RM, Nowak P, Perry KW, Kostrzewa JP.

Neurotox Res. 2003;5(5):329-38.

PMID:
14715452
7.

Modulation of the locomotor activating effects of the noncompetitive NMDA receptor antagonist MK801 by dopamine D2/3 receptor agonists in mice.

Cook CD, Newman JL, Winfree JC, Beardsley PM.

Pharmacol Biochem Behav. 2004 Feb;77(2):309-18.

PMID:
14751459
8.

The locomotor effects of quinpirole in rats depend on age and gender.

Frantz KJ, Van Hartesveldt C.

Pharmacol Biochem Behav. 1999 Dec;64(4):821-6.

PMID:
10593206
10.
11.
12.

K-channel blockers attenuate the presynaptic effects of the D2/D3 agonist quinpirole in monkeys.

Rosenzweig-Lipson S, Barrett JE.

Pharmacol Biochem Behav. 1995 Aug;51(4):843-8.

PMID:
7675867
13.
14.

Changes in behavioral sensitivity to SKF-38393 and quinpirole following withdrawal from continuous cocaine administration in rats.

Neisewander JL, Lucki I, McGonigle P.

Pharmacol Biochem Behav. 1996 Apr;53(4):935-42.

PMID:
8801600
15.

Effects of dose and interdose interval on locomotor sensitization to the dopamine agonist quinpirole.

Szechtman H, Dai H, Mustafa S, Einat H, Sullivan RM.

Pharmacol Biochem Behav. 1994 Aug;48(4):921-8.

PMID:
7972297
16.

Ontogenic homologous supersensitization of quinpirole-induced yawning in rats.

Kostrzewa RM, Brus R.

Pharmacol Biochem Behav. 1991 Jun;39(2):517-9.

PMID:
1682952
17.
18.

Effects of dopamine agonists and antagonists on locomotor activity in male and female rats.

Schindler CW, Carmona GN.

Pharmacol Biochem Behav. 2002 Jul;72(4):857-63.

PMID:
12062575
19.
20.

Kappa opioid mediated locomotor activity in the preweanling rat: role of pre- and postsynaptic dopamine receptors.

McDougall SA, Garmsen GM, Meier TL, Crawford CA.

Psychopharmacology (Berl). 1997 Sep;133(1):62-8.

PMID:
9335082

Supplemental Content

Support Center